About
Moletest (Scotland) Limited is the developer of nomela® a definitive 'rule-out' test for melanoma. We are an innovative independent British company dedicated to advancing melanoma screening and improving the patient pathway in dermatology care. The multidisciplinary team of experts at the heart of the company developed the technology that powers its melanoma screening test. This research has evolved into various forms of machine vision and signal analysis to ensure safe, robust and consistent performance. The end result is nomela®, a definitive ‘rule-out' medical device for suspected melanoma. Learn more: https://nomela.com/
Technologies
Route 53
Gmail
Google Apps
Linkedin Marketing Solutions
Squarespace ECommerce
Mobile Friendly
Typekit
Google Tag Manager
Google Analytics
Remote
AI
Keywords
backlog
cancer screening
patient referral system optimisation
melanoma screening
digital health
skin cancer screening
health tech
nhs digital
medical device
dermatology image processing
risk assessment
ai in dermatology
secure data transmission
deep learning
ai for pigmented lesions
secure healthcare it integration
dermatology ai system
risk assessment for melanoma
medical device software
dermatology
clinical screening support
automated edge detection
on-device ai analysis
on-device machine learning ai
healthcare cybersecurity
melanoma risk assessment
ai diagnostic accuracy
ai edge detection technology
medical equipment and supplies manufacturing
clinical screening aid
Company Information
-
Employees 2
-
Founded 2014
Location
Conference Square, Edinburgh, Scotland, United Kingdom, EH3 8
